ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Stryker Corp

Stryker Corp (SYK)

385.68
-3.00
(-0.77%)
Cerrado 20 Noviembre 3:00PM
386.91
1.23
( 0.32% )
Pre Mercado: 7:47AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
386.91
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
1,322
0.00 Rango del Día 0.00
285.79 Rango de 52 semanas 398.20
Capitalización de Mercado [m]
Precio Anterior
385.68
Precio de Apertura
-
Última hora de negociación
08:11:25
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,159,171
Acciones en circulación
381,215,773
Rendimiento del Dividendo
0.83%
Ratio Precio/Utilidad
46.45
Beneficio por acción (BPA)
8.3
turnover
20.5B
Beneficio neto
3.17B

Acerca de Stryker Corp

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. St... Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Nearly one fourth of Stryker's total revenue currently comes from outside the United States. Mostrar más

Sector
Surgical,med Instr,apparatus
Industria
Surgical,med Instr,apparatus
Sitio web
Sede
Plymouth, Michigan, USA
Fundado
-
Stryker Corp is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker SYK. The last closing price for Stryker was US$385.68. Over the last year, Stryker shares have traded in a share price range of US$ 285.79 to US$ 398.20.

Stryker currently has 381,215,773 shares in issue. The market capitalisation of Stryker is US$147.03 billion. Stryker has a price to earnings ratio (PE ratio) of 46.45.

Flujo de Opciones Stryker (SYK)

Flujo General

Pesimista

Prima Neta

-45k

Calls / Puts

33.33%

Comp. / Vent.

300.00%

OTM / ITM

300.00%

Sweeps Ratio

0.00%

SYK Últimas noticias

Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination

Stryker unveils Oculan Lighting Platform to enhance surgical visualization and illumination PR Newswire FLOWER MOUND, Texas, USA, Nov. 19, 2024 FLOWER MOUND, Texas, USA, Nov. 19, 2024...

Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment

Stryker launches next generation of SurgiCount+ to help improve the standard of care in hospitals for sponge management and blood loss assessment PR Newswire PORTAGE, Mich., USA, Nov. 14, 2024...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-4.44-1.13453430433391.35398.2381.091827960387.85638501CS
422.416.14814814815364.5398.2351.28571456029374.38608473CS
1228.627.98794272796358.29398.2343.951159171366.81459624CS
2657.5817.4839826314329.33398.2314.931209277350.19746727CS
5296.5733.2610043397290.34398.2285.791259879337.90926144CS
156122.746.4403315544264.21398.2188.841371127279.23023023CS
260182.9189.6617647059204398.2124.541380266253.30712121CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAMAA Mission Acquisition Corp
US$ 10.0507
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 10.93
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 10.89
(0.00%)
0
AAAlcoa Corporation
US$ 45.74
(0.00%)
12.84k
AAgilent Technologies
US$ 128.57
(0.00%)
4.93k
AAMAA Mission Acquisition Corp
US$ 10.0507
(0.00%)
0
AACT.UAres Acquisition Corporation II
US$ 10.93
(0.00%)
0
AACTAres Acquisition Corporation II
US$ 10.89
(0.00%)
0
AAAlcoa Corporation
US$ 45.74
(0.00%)
12.84k
AAgilent Technologies
US$ 128.57
(0.00%)
4.93k
CTVInnovid Corp
US$ 1.62
(0.00%)
7M
SNOWSnowflake Inc
US$ 129.12
(0.00%)
2.3M
TOSTToast Inc
US$ 42.50
(0.00%)
2.08M
PLTRPalantir Technologies Inc
US$ 62.12
(0.00%)
1.74M
NIONIO Inc
US$ 4.65
(0.00%)
1.47M

SYK Discussion

Ver más
Monksdream Monksdream 2 semanas hace
SYK, new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 3 semanas hace
Hasn't broken down yet. Patiently waiting for the cycle to start again. I'll bet this gets down below $300 before years end.
👍️0
Monksdream Monksdream 2 meses hace
SYK new 52=week high
👍️0
LORTAP KCOTS LORTAP KCOTS 7 meses hace
I’ll start setting my buys for $292.00, hopefully it does the classic retrace after earnings
👍️0
Monksdream Monksdream 7 meses hace
SYK 10Q due 4/30
👍️0
Monksdream Monksdream 8 meses hace
SYK new 52 week hi
👍️0
LORTAP KCOTS LORTAP KCOTS 9 meses hace
Crazy
👍️0
Monksdream Monksdream 9 meses hace
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 9 meses hace
Crazy especially because there are a ton of insiders selling.
My buy back in price is at $270 now.
Might be a while before this goes back down 20%, but historically it will at some point..
👍️0
Monksdream Monksdream 9 meses hace
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 10 meses hace
New 52!!
Reload at 270 when the new higher low happens.
👍️0
LORTAP KCOTS LORTAP KCOTS 10 meses hace
Love to see it consistently do it’s magic
👍️0
Monksdream Monksdream 10 meses hace
SYK new 52 week high
👍️0
Monksdream Monksdream 10 meses hace
SYK new 52 week high
👍️0
LORTAP KCOTS LORTAP KCOTS 1 año hace
Thank you SYK..
Another $52,000 profit in a quick 1 month flip.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Gonna get another 1000 shares on Monday
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Bought a ton at $250
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Started buying in at $257.25.
Getting some $255 shares today as well.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Gonna put in buy orders at $239, stupid markets about to roll over and this will be a safe entrance
👍️0
larry77 larry77 3 años hace
has everyone gone to sleep on this? WTF?
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Sold 272.12, waiting to reload at $245
Made $33,000 last trade.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Got filled 249 today, ready sell orders to unload at 269 again..
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Made $13,000 on SYK trade.
Reloading at $250
👍️0
LORTAP KCOTS LORTAP KCOTS 3 años hace
Picked up 1000 shares@258.50, let’s roll this into some bank at $278.50!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 5 años hace
Murder on the wall street this week
👍️0
LORTAP KCOTS LORTAP KCOTS 5 años hace
Crushed today.
👍️0
flyonthewall flyonthewall 5 años hace
I agree bro. Check out SECI only 306,000 shares exist and a multi billion settlement deadline is scheduled by the Judge for February 7, 2020 otherwise Trial starts in May of 2020. Literally Billions on the line here. Just a 1 Billion Dollar Judgement or Settlement would create 1 share with an approximate Value of $3,200. A perfect storm is happening here for a massive payout on technology that was stolen and intended to save FireFighters lives giving us real time GPS Tracking and VoIP Communications.
👍️0
LORTAP KCOTS LORTAP KCOTS 5 años hace
The best secret stock to keep long term
👍️0
flyonthewall flyonthewall 5 años hace
Good to know. Yes that is also what I figured. This company produces amazing medical devices that there will always be a demand for in the Emergency Medical Services sector.
👍️0
Striker77 Striker77 5 años hace
Its always a great hold. Worth at least 220 right now. Only down because some didnt like the acquisition last week.
👍️0
flyonthewall flyonthewall 5 años hace
SYK going higher from here longs ? I have December 210 calls. Anyone have ideas on how SYK should do on this upcoming earnings ?
👍️0
LORTAP KCOTS LORTAP KCOTS 5 años hace
Sold a trading position at $210.50, will buy back at $192.50
That’s the plan, as I bought the shares at $175, 3 months ago.
👍️0
pontiacg6 pontiacg6 6 años hace
Former MAKO CEO JOINS TITAN MEDICAL - TICKER TMDI

https://apple.news/AgYXFxFsEROmMHtrBEJGGFQ

MAKO GOT BOUGHT BY STRYKER MAYBE TMDI NEXT
👍️0
LORTAP KCOTS LORTAP KCOTS 6 años hace
Boom another all time high!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 años hace
All time high again
👍️0
PennyStock Alert PennyStock Alert 6 años hace
Almost all time high
👍️0
PennyStock Alert PennyStock Alert 6 años hace
YIELD GROWTH Announces Healthy Planet Canada, an Independent Health and Wellness Company with 24 Ontario Retail Locations
👍️0
PennyStock Alert PennyStock Alert 6 años hace
Stryker acquires Arrinex

Source: GlobeNewswire Inc.

Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the treatment of chronic rhinitis. This condition, which affects over 24 million people in the U.S. each year, may cause runny nose, congestion, sneezing and nasal itching. Arrinex, which was founded in 2013, began commercializing ClariFix in late 2017 in the U.S. ClariFix further expands Stryker’s Ear, Nose and Throat (ENT) portfolio with a unique product to address a large, underpenetrated segment of the ENT market where Stryker does not currently compete.
“The acquisition of Arrinex is highly complementary to Stryker’s ENT portfolio, which is part of our Neurotechnology business,” said Spencer Stiles, Stryker’s Group President, Neurotechnology, Instruments and Spine. “This acquisition aligns with our focus on providing ENT physicians with new technologies that deliver more treatment options and better patient outcomes.”

Forward-looking statements
👍️0
PennyStock Alert PennyStock Alert 6 años hace
Small dip
👍️0
LORTAP KCOTS LORTAP KCOTS 6 años hace
Another all time high!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 años hace
And another one
👍️0
LORTAP KCOTS LORTAP KCOTS 6 años hace
New 52 week high!
👍️0
LORTAP KCOTS LORTAP KCOTS 6 años hace
Awesome day!
👍️0
LORTAP KCOTS LORTAP KCOTS 7 años hace
New 52 week highs
👍️0
LORTAP KCOTS LORTAP KCOTS 7 años hace
Up $11 boom
👍️0
LORTAP KCOTS LORTAP KCOTS 7 años hace
Got a bunch of shares yesterday for cheap..!
Now those will be up $10 in the next week.
👍️0
LORTAP KCOTS LORTAP KCOTS 7 años hace
New all time high
👍️0
stealthways stealthways 7 años hace
think Stryker has been very complacent about emerging tech ,mainly due to its leading strength in the Ortho segment (this is not uncommon in various industries and the skeletons of similarly over confident companies are littered) --- and has failed to see how significant the dangers are of transformational tech. The bashers of the AMDA stock, don't kid yourself, has also affected the Stryker over confidence with their own tech.. "Asleep at the switch" comes to mind....

Lets assume that Stryker, for what ever reason, "wakes up", from its tech hibernation, and see that AMDA is cleaning the books, auditing assets etc, and other hallmarks of a potential sale. Lets further assume, they understand how AMDA tech would likely help Zimmer take many Billions of their revenue away over the next 5 to 10 years and add incremental new revenue, from new sources, to Zimmer..
If you look at Strykers history, it looks to me to have more experience than Zimmer at growing by acquisition ... Even if Stryker has some kind of relationship with Zimmer currently likely this would be superficial. Anyways, based on these assumptions, why would Stryker sit back and let this deal happen with no interference (i.e. competing bid) from it .... even if they know of the personal connections between AMDA and Zimmer. So for example lets says Stryker calculates an AMDA sale to Zimmer would take $5 Billion off the Present Value (roughly equal to market cap) of Stryker.. and lets say Zimmer trys to low ball a $100 million bid for AMDA... Under this scenario, no matter what relationships are, it would make no sense for Stryker to just sit back and let this deal happen with no response. Even if Stryker thinks Zimmer may potentially outbid them , its better for Stryker to have Zimmer pay up at least , if they do succeed.

Bottom line is Stryker needs to wake up to emerging tech and protect their future by trying to own the tech at AMDA....The bashing and manipulation of AMDA hides the true value, and danger if in the hand of a competitor, of the technology..time is of the essence...
👍️0
stealthways stealthways 7 años hace
Amedica books have been recently getting cleaned up and assets audited at Amedica, prepping for a sale, so Stryker could be successful in a quick purchase of Amedica. Japan approval is coming and China is ready also... Lobo needs to give this a priority in Business Development..
👍️0
stealthways stealthways 7 años hace
Lobo needs to act quick ....Stryker has a chance to acquire Amedica and its tech before Zimmer Biomet. If Stryker, drops the ball, and allows Zimmer to get Amedica, with world wide patents for its new SiNi, 3-D printing tech, main asian markets near approval, anti-infective properties, and many more advantages, Zimmer will be a tough night in Hip-knee, and gain share in spine .... It is simple for Stryker to block Zimmer, if they act quick.... Zimmer is preparing now to acquire this tech but Stryker , by using its superior M&A skills can be quicker and block this threat ....
👍️0

Su Consulta Reciente

Delayed Upgrade Clock